大象传媒

There's excitement over a new cancer treatment, in which early tests show remarkable results in a therapy that retrains the body's immune system. In the trial, white blood cells were taken from patients with leukaemia, modified in the lab and then put back. 90% of terminally ill patients reportedly went into remission. But the results are being treated with caution, as none of the data has been published or reviewed. We speak to experts, journalists and cancer survivors about what the way trials like this are reported and received.

And, we hear from Syrian blogger and activist, Marcell Shehwaro about her life in Aleppo

Image: Light micrograph of blood cells sampled from a lymphatic ganglion, in a case of lymphocytic leukaemia
Credit: Science Photo Library